BOSTON – May 1, 2023 – David J. Dykeman, co-chair of the Life Sciences & Medical Technology Practice of global law firm Greenberg Traurig, LLP and co-managing shareholder of the firm’s Boston office, and Roman Fayerberg, shareholder of the firm’s Boston office, will present on the DeviceTalks Boston panel, “IP Strategy to Attract Funding & Exits,” May 10.
The panel will focus on how Intellectual Property (IP) is key for medical technology companies to secure funding and exits. Additional panelists include Addie Harris, CEO of Haventure, and Jeremy Sohn, managing general partner at P74 Ventures. The panelists will provide insight on creating a strategic and competitive patent portfolio to close funding and secure exits.
A registered patent attorney with 25 years of experience in patent and IP law, Dykeman focuses his practice on securing worldwide IP protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. Dykeman provides strategic patent portfolio development and IP advice for clients, including major research institutions, multinational corporations, and early-stage companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities. An author of over 55 articles and a speaker at over 50 conferences on IP law, Dykeman is the founding co-chair of the American Bar Association’s Medical Devices Committee. In 2022, Dykeman was named “Patent Strategy Attorney of the Year for Massachusetts” by LMG Life Sciences.
Fayerberg is a registered patent attorney with broad experience helping clients strategically protect and leverage their innovations globally. He works with clients to develop and manage worldwide patent portfolios and counsels clients regarding freedom to operate, patent landscape, and patent infringement and validity matters. Fayerberg also conducts and defends patent due diligence investigations in connection with venture capital investments, mergers and acquisitions, and licensing opportunities. Fayerberg has represented clients ranging from startups to global companies in a variety of technical areas, including medical devices, robotics, diagnostic and imaging systems, microfluidic devices, and biotechnology.